2012 annual financial data
Theravance Biopharma 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -91.52%.
Operating income was -9,575,000 USD and net income was -9,575,000 USD.
Operating cash flow was -119,107,000 USD.
Get free Theravance Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 130,145,000 USD
- Operating income
- -9,575,000 USD
- Net income
- -9,575,000 USD
- Operating cash flow
- -119,107,000 USD